Detalles de la búsqueda
1.
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
Lancet
; 392(10163): 2441-2451, 2018 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30360964
2.
Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials.
J Drugs Dermatol
; 17(2): 200-206, 2018 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29462229
3.
Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
J Clin Psychopharmacol
; 34(1): 9-16, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24346757
4.
Evaluation of the effects of duloxetine and escitalopram on 24-hour heart rate variability: a mechanistic study using heart rate variability as a pharmacodynamic measure.
J Clin Psychopharmacol
; 33(2): 236-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23422380
5.
Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies.
Prim Care Companion J Clin Psychiatry
; 8(5): 269-78, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17235383
6.
Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience.
Med Devices (Auckl)
; 9: 361-369, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27785115
7.
Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
J Clin Psychiatry
; 77(5): 635-42, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27035159
8.
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 25(4): 293-305, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25978741
9.
A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
J Am Acad Child Adolesc Psychiatry
; 54(4): 283-93, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25791145
10.
Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder.
Drugs Context
; 4: 212279, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26005493
11.
Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence.
Prim Care Companion J Clin Psychiatry
; 6(2): 65-73, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15254599
12.
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 24(4): 170-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24815533
13.
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 24(4): 180-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24813026
14.
Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Clin J Pain
; 28(9): 775-81, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22971669
15.
An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression.
J Child Adolesc Psychopharmacol
; 22(1): 48-55, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22251023
16.
A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder.
J Psychiatr Res
; 45(6): 748-55, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21511276
17.
Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials.
Curr Med Res Opin
; 26(11): 2643-51, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20932222
18.
Hepatic effects of duloxetine-I: non-clinical and clinical trial data.
Curr Drug Saf
; 3(2): 132-42, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18690991
19.
Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.
J Clin Psychopharmacol
; 25(2): 132-40, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15738744
Resultados
1 -
19
de 19
1
Próxima >
>>